Janumet XR is a type of combination drug that helps to control blood glucose levels in diabetic individuals. It contains two different antidiabetic drugs: extended-release metformin hydrochloride (500mg) and immediate-release sitagliptin (50mg). Metformin hydrochloride belongs to a class of antidiabetic medicines called biguanides, while sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor.
Apart from 50mg/500mg, Janumet XR also comes in the dosage strengths of 50mg/1000mg and 100mg/1000mg. The drug is formulated as film-coated, oval tablets. This diabetes medicine is manufactured by Merck, a leading pharmaceutical company headquartered in New Jersey, United States. The drug is available in the generic brand of metformin/sitagliptin. The box contains a product leaflet, which contains all the essential information about Janumet XR. Read carefully before use.
Janumet XR is indicated for the improvement of glycemic control in diabetes patients. For optimal treatment outcomes, this medication should be used as part of a management plan consisting of exercise and a healthy diet. This drug should only be used to treat type II diabetes. The drug is intended for use in adult patients only.
Patients with diabetes (in particular, diabetes II) should use Janumet to improve their blood sugar control.